These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10539014)

  • 41. Perspectives. Gore: more funds for Medicare, incremental steps for access.
    Clemmitt M
    Med Health; 2000 Jul; 54(27):suppl 1-4. PubMed ID: 11066633
    [No Abstract]   [Full Text] [Related]  

  • 42. Caught in between: prescription drug coverage of Medicare beneficiaries near poverty.
    Shea DG; Stuart BC; Briesacher B
    Issue Brief (Commonw Fund); 2003 Aug; (669):1-8. PubMed ID: 12926411
    [No Abstract]   [Full Text] [Related]  

  • 43. Finance issue brief: mandated benefits: off-label drug coverage requirements: year end report-2003.
    Plaza CI
    Issue Brief Health Policy Track Serv; 2003 Dec; ():1-9. PubMed ID: 14870745
    [No Abstract]   [Full Text] [Related]  

  • 44. Pharmaceuticals, finance issue brief: mandated benefits: off-label drug coverage.
    Plaza CI
    Issue Brief Health Policy Track Serv; 2000 Jun; ():1-5. PubMed ID: 11073410
    [No Abstract]   [Full Text] [Related]  

  • 45. Medicare's spin cycle.
    Bloice C
    Revolution (Oakl); 2002; 3(2):4-5. PubMed ID: 11949233
    [No Abstract]   [Full Text] [Related]  

  • 46. Private, individual drug coverage in the current Medicare market.
    Boccuti C; Moon M
    Policy Brief Commonw Fund; 2003 Oct; (679):1-10. PubMed ID: 14562796
    [No Abstract]   [Full Text] [Related]  

  • 47. Medicare payments to increase as part of Rx drug bill.
    Fam Pract Manag; 2004 Jan; 11(1):25. PubMed ID: 14748240
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmaceuticals: Medicare Modernization Act.
    Hilyard K; Howe WC
    Issue Brief Health Policy Track Serv; 2007 Jan; ():1-28. PubMed ID: 17361467
    [No Abstract]   [Full Text] [Related]  

  • 49. Sex discrimination or a hard pill for employers to swallow: examining the denial of contraceptive benefits in the wake of Erickson v. Bartell Drug Co.
    Korland L
    Case West Reserve Law Rev; 2002; 53(2):531-67. PubMed ID: 16506335
    [No Abstract]   [Full Text] [Related]  

  • 50. Prescription drug pricing: the consumer perspective.
    Searing A
    N C Med J; 2003; 64(6):300-2. PubMed ID: 14983625
    [No Abstract]   [Full Text] [Related]  

  • 51. Pharmaceuticals issue brief: pharmaceutical assistance for the elderly.
    Hackney C
    Issue Brief Health Policy Track Serv; 2000 Jul; ():1-10. PubMed ID: 11073431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insurance coverage and health care use among near-elderly women.
    Xu X; Patel DA; Vahratian A; Ransom SB
    Womens Health Issues; 2006; 16(3):139-48. PubMed ID: 16765290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug insurance for the elderly moves ahead in Congress.
    Greenberg DS
    Lancet; 2000 Jul; 356(9223):51. PubMed ID: 10892773
    [No Abstract]   [Full Text] [Related]  

  • 54. Finance issue brief: mandated benefits: osteoporosis coverage requirements: year end report-2003.
    Plaza CI
    Issue Brief Health Policy Track Serv; 2003 Dec; ():1-4. PubMed ID: 14870744
    [No Abstract]   [Full Text] [Related]  

  • 55. How should Medicare structure drug benefits?
    Frenkel M
    J Med Pract Manage; 1999; 15(1):5-6. PubMed ID: 10662277
    [No Abstract]   [Full Text] [Related]  

  • 56. State regulation of private health insurance: prescription drug benefits, experimental treatments, and consumer protection.
    Bolin JN; Buchanan RJ; Smith SR
    Am J Manag Care; 2002 Nov; 8(11):977-85. PubMed ID: 12437312
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Should prescription plans cover Viagra?
    Moreno JD
    J Androl; 1999; 20(2):196-7. PubMed ID: 10232654
    [No Abstract]   [Full Text] [Related]  

  • 58. Perspectives. House Medicare Rx bill: doing what it takes for choice?
    Clemmitt M
    Med Health; 2000 Jul; 54(29):suppl 1-4. PubMed ID: 11066634
    [No Abstract]   [Full Text] [Related]  

  • 59. [The condition--not the drug--is decisive when it comes to subsidizing. Increased objectivity in the debate on subsidized "quality of life drugs" is required].
    Landtblom AM; Ertzgaard P
    Lakartidningen; 2000 May; 97(21):2612-4. PubMed ID: 10881521
    [No Abstract]   [Full Text] [Related]  

  • 60. Medicare/prescription drug benefit in the crossfire.
    Halamandaris VJ
    Caring; 2004 Jun; 23(6):56. PubMed ID: 15270333
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.